A deadly disorder: During the pregnancy, doctors detected swelling, severe anemia, and a lack of oxygen in the fetus. The life-threatening symptoms were caused by alpha thalassemia major, a genetic blood disorder. Most babies with the condition are stillborn or die soon after birth.
The procedure: A team at the University of California, San Francisco extracted bone marrow from the mother-to-be between the 18th and 25th weeks of pregnancy and isolated stem cells from it. They then injected the cells into the fetus’s umbilical vein, allowing them to circulate through the bloodstream and develop into healthy blood cells.
Healthy baby: The infant was born in February, four months after undergoing the stem-cell transplant (that’s her, pictured above with her parents). It’s too early to know whether the treatment is a cure, but doctors hope to use the approach to eliminate beta thalassemia, the more common form of the disease, as well as sickle-cell anemia and other serious genetic disorders.
How scientists want to make you young again
Research labs are pursuing technology to “reprogram” aging bodies back to youth.
Inside the billion-dollar meeting for the mega-rich who want to live forever
Hope, hype, and self-experimentation collided at an exclusive conference for ultra-rich investors who want to extend their lives past 100. I went along for the ride.
Human brain cells transplanted into baby rats’ brains grow and form connections
When lab-grown clumps of human neurons are transplanted into newborn rats, they grow with the animals. The research raises some tricky ethical questions.
The debate over whether aging is a disease rages on
In its latest catalogue of health conditions, the World Health Organization almost equated old age with disease. Then it backed off.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.